Abstract:During the SARS-CoV-2-associated infection (COVID-19), pandemic initial reports suggested relative sparing of children inversely related to their age. Children and neonates have a decreased incidence of SARS-CoV-2 infection, and if infected they manifested a less severe phenotype, in part due to enhanced innate immune response. However, a multisystem inflammatory syndrome in children (MIS-C) or paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 emerged involving coronary artery aneurysms, cardiac dysfunction, and multiorgan inflammatory manifestations. MIS-C has many similarities to Kawasaki disease and other inflammatory conditions and may fit within a spectrum of inflammatory conditions based on immunological results. More recently neonates born to mothers with SARS-CoV-2 infection during pregnancy demonstrated evidence of a multisystem inflammatory syndrome with raised inflammatory markers and multiorgan, especially cardiac dysfunction that has been described as multisystem inflammatory syndrome in neonates (MIS-N). However, there is a variation in definitions and management algorithms for MIS-C and MIS-N. Further understanding of baseline immunological responses to allow stratification of patient groups and accurate diagnosis will aid prognostication, and inform optimal immunomodulatory therapies. IMPACT: Multisystem inflammatory system in children and neonates (MIS-C and MIS-N) post COVID require an internationally recognized consensus definition and international datasets to improve management and plan future clinical trials. This review incorporates the latest review of pathophysiology, clinical information, and management of MIS-C and MIS-N. Further understanding of the pathophysiology of MIS-C and MIS-N will allow future targeted therapies to prevent and limit clinical sequelae.

Role of Percutaneous ECMO and Balloon Atrial Septostomy in Multi-System Inflammatory Syndrome in Children

Extracorporeal Membrane Oxygenation for COVID-19-Associated Multisystem Inflammatory Syndrome in a 5-year-old

"Extracorporeal membrane oxygenation outcomes in multisystem inflammatory syndrome of childhood – An extracorporeal life support organization registry study",

Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

Clinical Application of Extracorporeal Membrane Oxygenation in Children with Refractory Cardiopulmonary Failure

[Extracorporeal Membrane Oxygenation for Rescuing 12 Children with Acute Fulminant Myocarditis].

Multisystem Inflammatory Syndrome in Children during the COVID-19 Pandemic: A Review of Clinical Manifestations, Cardiac Complications and Medical Management

Extracorporeal membrane oxygenation for the treatment of children with severe hemodynamic alteration in perioperative cardiovascular surgery

Efficacy of CytoSorb in a Pediatric Case of Severe Multisystem Infammatory Syndrome (MIS-C): A Clinical Case Report

Long-Term Cardiovascular Outcomes of Multisystem Inflammatory Syndrome in Children Associated with COVID-19 Using an Institution Based Algorithm

Role of matrix metalloproteinases in multi-system inflammatory syndrome and acute COVID-19 in children

Local Experience With Extracorporeal Membrane Oxygentaion In Children With Acute Fulminant Myocarditis

Perioperative Extracorporeal Membrane Oxygenation in Pediatric Congenital Heart Disease: Chinese Expert Consensus

Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management

Managing medically refractory elevated intracranial pressure in a pediatric patient on ECMO: illustrative case

Structured review of post-cardiotomy extracorporeal membrane oxygenation: Part 2-pediatric patients

Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2

Extracorporeal membrane oxygenation (ECMO) support for children with pulmonary hypertension: A single‐institutional experience of outcomes

All hands on deck: A multidisciplinary approach to SARS-CoV-2-associated MIS-C

Emergent veno-arterial extra-corporeal membrane oxygenator support for refractory acute myocarditis in paediatric patients

Emergency myelopoiesis distinguishes multisystem inflammatory syndrome in children from pediatric severe COVID-19